Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Identification of two novel Shank3 transcripts in the developing mouse neocortex.

Waga C, Asano H, Sanagi T, Suzuki E, Nakamura Y, Tsuchiya A, Itoh M, Goto Y, Kohsaka S, Uchino S.

J Neurochem. 2014 Jan;128(2):280-93. doi: 10.1111/jnc.12505. Epub 2013 Nov 14.

2.

SHANK3 as an autism spectrum disorder-associated gene.

Uchino S, Waga C.

Brain Dev. 2013 Feb;35(2):106-10. doi: 10.1016/j.braindev.2012.05.013. Epub 2012 Jun 29. Review.

PMID:
22749736
3.

Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes.

Kerr B, Soto C J, Saez M, Abrams A, Walz K, Young JI.

Eur J Hum Genet. 2012 Jan;20(1):69-76. doi: 10.1038/ejhg.2011.145. Epub 2011 Aug 10.

4.

Developmental profiling of ASD-related shank3 transcripts and their differential regulation by valproic acid in zebrafish.

Liu CX, Peng XL, Hu CC, Li CY, Li Q, Xu X.

Dev Genes Evol. 2016 Nov;226(6):389-400. Epub 2016 Aug 26.

5.

Differential Expression and Regulation of Brain-Derived Neurotrophic Factor (BDNF) mRNA Isoforms in Brain Cells from Mecp2(308/y) Mouse Model.

Rousseaud A, Del├ępine C, Nectoux J, Billuart P, Bienvenu T.

J Mol Neurosci. 2015 Aug;56(4):758-67. doi: 10.1007/s12031-014-0487-0. Epub 2015 Jan 30.

PMID:
25634725
6.

Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome.

Moretti P, Levenson JM, Battaglia F, Atkinson R, Teague R, Antalffy B, Armstrong D, Arancio O, Sweatt JD, Zoghbi HY.

J Neurosci. 2006 Jan 4;26(1):319-27.

7.

Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.

Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF, Kang D, Richman R, Johnson JM, Berget S, Zoghbi HY.

Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17551-8. Epub 2005 Oct 26. Erratum in: Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1656.

8.

Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.

Itoh M, Ide S, Takashima S, Kudo S, Nomura Y, Segawa M, Kubota T, Mori H, Tanaka S, Horie H, Tanabe Y, Goto Y.

J Neuropathol Exp Neurol. 2007 Feb;66(2):117-23.

PMID:
17278996
9.

Novel Therapeutic Approach for Autism Spectrum Disorder: Focus on SHANK3.

Uchino S, Waga C.

Curr Neuropharmacol. 2015;13(6):786-92. Review.

10.

Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3.

Wang X, McCoy PA, Rodriguiz RM, Pan Y, Je HS, Roberts AC, Kim CJ, Berrios J, Colvin JS, Bousquet-Moore D, Lorenzo I, Wu G, Weinberg RJ, Ehlers MD, Philpot BD, Beaudet AL, Wetsel WC, Jiang YH.

Hum Mol Genet. 2011 Aug 1;20(15):3093-108. doi: 10.1093/hmg/ddr212. Epub 2011 May 10.

11.

Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes.

Zachariah RM, Olson CO, Ezeonwuka C, Rastegar M.

PLoS One. 2012;7(11):e49763. doi: 10.1371/journal.pone.0049763. Epub 2012 Nov 19.

12.

Isoform-specific toxicity of Mecp2 in postmitotic neurons: suppression of neurotoxicity by FoxG1.

Dastidar SG, Bardai FH, Ma C, Price V, Rawat V, Verma P, Narayanan V, D'Mello SR.

J Neurosci. 2012 Feb 22;32(8):2846-55. doi: 10.1523/JNEUROSCI.5841-11.2012.

13.
14.

Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders.

Zhu L, Wang X, Li XL, Towers A, Cao X, Wang P, Bowman R, Yang H, Goldstein J, Li YJ, Jiang YH.

Hum Mol Genet. 2014 Mar 15;23(6):1563-78. doi: 10.1093/hmg/ddt547. Epub 2013 Nov 1.

15.

MeCP2 is required for normal development of GABAergic circuits in the thalamus.

Zhang ZW, Zak JD, Liu H.

J Neurophysiol. 2010 May;103(5):2470-81. doi: 10.1152/jn.00601.2009. Epub 2010 Mar 3.

16.

Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements.

Olson CO, Zachariah RM, Ezeonwuka CD, Liyanage VR, Rastegar M.

PLoS One. 2014 Mar 3;9(3):e90645. doi: 10.1371/journal.pone.0090645. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e101030.

17.

Altered Striatal Synaptic Function and Abnormal Behaviour in Shank3 Exon4-9 Deletion Mouse Model of Autism.

Jaramillo TC, Speed HE, Xuan Z, Reimers JM, Liu S, Powell CM.

Autism Res. 2016 Mar;9(3):350-75. doi: 10.1002/aur.1529. Epub 2015 Nov 11.

18.

A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.

Buschdorf JP, Str├Ątling WH.

J Mol Med (Berl). 2004 Feb;82(2):135-43. Epub 2003 Nov 15.

PMID:
14618241
19.

Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations.

Farra N, Zhang WB, Pasceri P, Eubanks JH, Salter MW, Ellis J.

Mol Psychiatry. 2012 Dec;17(12):1261-71. doi: 10.1038/mp.2011.180. Epub 2012 Jan 10.

20.

The methyl-CpG-binding protein MeCP2 and neurological disease.

Bird A.

Biochem Soc Trans. 2008 Aug;36(Pt 4):575-83. doi: 10.1042/BST0360575.

PMID:
18631120

Supplemental Content

Support Center